Flow cytometry-based FRET identifies binding intensities in PPARγ1 protein-protein interactions in living cells.
Ontology highlight
ABSTRACT: PPARγ is a pharmacological target in inflammatory and metabolic diseases. Upon agonistic treatment or following antagonism, binding of co-factors is altered, which consequently affects PPARγ-dependent transactivation as well as its DNA-independent properties. Therefore, establishing techniques to characterize these interactions is an important issue in living cells. Methods: Using the FRET pair Clover/mRuby2, we set up a flow cytometry-based FRET assay by analyzing PPARγ1 binding to its heterodimerization partner RXRα. Analyses of PPARγ-reporter and co-localization studies by laser-scanning microscopy validated this system. Refining the system, we created a new readout to distinguish strong from weak interactions, focusing on PPARγ-binding to the co-repressor N-CoR2. Results:
SUBMITTER: Trumper V
PROVIDER: S-EPMC6735382 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA